These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34519585)

  • 1. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
    Zhong M; Zhang Y; Pan Z; Wang W; Zhang Y; Weng Y; Huang H; He Y; Liu O
    Technol Cancer Res Treat; 2021; 20():15330338211041465. PubMed ID: 34519585
    [No Abstract]   [Full Text] [Related]  

  • 2. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
    Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
    BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
    Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
    J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
    Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
    Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Beinert T; Fürst H; Fink U
    Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of Combined Detection of Cytokines and Tumor Markers in the 
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
    Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
    Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
    Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
    Zhang W; Duan X; Zhang Z; Yang Z; Zhao C; Liang C; Liu Z; Cheng S; Zhang K
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33905377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
    Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
    J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
    Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study.
    He Y; Shi J; Shi G; Xu X; Liu Q; Liu C; Gao Z; Bai J; Shan B
    Sci Rep; 2017 Aug; 7(1):9542. PubMed ID: 28842574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research Progresses of Circulating Tumor Cells in Diagnosis and Treatment of 
Early Lung Cancer].
    Duan X; Liu Z; Xu S
    Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):703-709. PubMed ID: 29061218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
    Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
    Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
    Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of conventional tumor markers in young patients with pulmonary nodules.
    Xu L; Su Z; Xie B
    J Clin Lab Anal; 2021 Sep; 35(9):e23912. PubMed ID: 34296781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
    Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
    PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients.
    Wang X; Ma K; Wang Y; He H; Hu JF; Li W
    Arch Med Res; 2016 Aug; 47(6):454-459. PubMed ID: 27986125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.